OOIR: Observatory of International Research

Papers

(The H4-Index of Thrombosis Research is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Age over 75 does not increase the risk of recurrent venous thromboembolism: Findings from the RIETE registry	86
The value of the CHAP model for prediction of the bleeding risk in patients with unprovoked venous thromboembolism: Findings from the RIETE registry	79
Safety and effectiveness of a risk-stratified venous thromboembolism prophylaxis algorithm in young people with cystic fibrosis	63
Venous thromboembolism associates with SARS-CoV-2 more than seasonal influenza	63
Extended-duration thromboprophylaxis following major abdominopelvic surgery – For everyone or selected cases only?	62
DOAC drug levels: Does “knowing” lead to safer care?	53
Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?	49
Validation of the Academic Research Consortium for High Bleeding Risk criteria in Chinese patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention	47
PO-99 Non-traumatic subdural hematoma and occult cancer: a Danish nationwide cohort study	47
PO-82 Impede VTE vs saved scores to predict the risk of venous thromboembolism in newly diagnosed multiple myeloma with immunomodulatory drugs: how to choose?	47
Exploration of rotational thromboelastometry (ROTEM) to characterize the coagulation profiles of newly diagnosed pediatric leukemia patients	46
Thromboelastometry in daily obstetric practice: At what amount of blood loss do we find abnormal results? A retrospective clinical observational study	44
Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study	41
DOACs: A perfect fit for patients with bariatric surgery?	40
Impact of direct oral anticoagulants on evolution of post-thrombotic syndrome	39
Quality and predictors of oral anticoagulation therapy with vitamin K antagonists in adult congenital heart disease: TTR and INR variability	36
Anticoagulation with argatroban using hemoclot™ targets is safe and effective in CARDS patients receiving venovenous extracorporeal membrane oxygenation: An exploratory bi-centric cohort study	35
External validation of a model to predict women most at risk of postpartum venous thromboembolism: Maternity clot risk	34
Tigecycline-associated hypofibrinogenemia: A single center, retrospective, controlled study	34
Decreased patency of transjugular intrahepatic portosystemic shunts performed for splanchnic vein thrombosis in patients with myeloproliferative neoplasms	32
Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study	32
Absence of COVID-19-associated changes in plasma coagulation proteins and pulmonary thrombosis in the ferret model	31
Efficacy and safety of genotype-guided warfarin dosing versus non-genotype-guided warfarin dosing strategies: A systematic review and meta-analysis of 27 randomized controlled trials	30
Development and validation of an in vitro model to study thrombin generation on the surface of catheters in platelet-poor and platelet-rich plasma	29
Comparative analysis of Lox-1 and CD36 expression in human platelets and on circulating microparticles during ARDS-induced coagulopathy	29

Corrigendum to “Repurposing of rilpivirine for preventing platelet β3 integrin-dependent thrombosis by targeting c-Src active autophosphorylation” [Thromb. Res. 229 (2023) 53–68]	28
Inferior vena cava contrast reflux grade is associated with a reduced cardiac index in acute pulmonary embolism	28
Complement system activation through the alternative pathway associates with disseminated intravascular coagulation to increase mortality in sepsis	27